193 related articles for article (PubMed ID: 1702492)
1. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
Sanders KH; Beller KD; Kolassa N
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
[TBL] [Abstract][Full Text] [Related]
2. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
Sanders KH; Beller KD; Bischler P; Kolassa N
J Hypertens Suppl; 1988 Dec; 6(2):S65-8. PubMed ID: 2906703
[TBL] [Abstract][Full Text] [Related]
3. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
Kolassa N; Beller KD; Sanders KH
Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
[TBL] [Abstract][Full Text] [Related]
4. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
Valenta B; Kotai E; Weisz E; Singer EA
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
[TBL] [Abstract][Full Text] [Related]
5. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
[TBL] [Abstract][Full Text] [Related]
6. Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors.
Mandal AK; Zhong PY; Kellar KJ; Gillis RA
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S49-60. PubMed ID: 1702487
[TBL] [Abstract][Full Text] [Related]
7. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
Mandal AK; Kellar KJ; Friedman E; Pineo SV; Hamosh P; Gillis RA
J Pharmacol Exp Ther; 1989 Nov; 251(2):563-70. PubMed ID: 2530339
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
Dabiré H; Laubie M; Schmitt H
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S61-7. PubMed ID: 1702488
[TBL] [Abstract][Full Text] [Related]
9. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
Deckert V; Chaouloff F; Richer C; Elghozi JL
Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
[TBL] [Abstract][Full Text] [Related]
10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
Millan MJ; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380
[TBL] [Abstract][Full Text] [Related]
12. Central nervous actions of serotonin and a serotonin1A receptor agonist: cardiovascular excitation at low doses.
Dedeoğlu A; Fisher LA
J Pharmacol Exp Ther; 1991 Apr; 257(1):425-32. PubMed ID: 1826928
[TBL] [Abstract][Full Text] [Related]
13. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
Gillis RA; Hill KJ; Kirby JS; Quest JA; Hamosh P; Norman WP; Kellar KJ
J Pharmacol Exp Ther; 1989 Feb; 248(2):851-7. PubMed ID: 2521902
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
15. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
[TBL] [Abstract][Full Text] [Related]
16. Are drugs that act both on serotonin receptors and alpha 1-adrenoceptors more potent hypotensive agents than those that act only on alpha 1-adrenoceptors?
Ramage AG
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S30-4. PubMed ID: 2459511
[TBL] [Abstract][Full Text] [Related]
17. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
Dreteler GH; Wouters W; Saxena PR
Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bladder activity by 5-hydroxytryptamine1 serotonin receptor agonists in cats with chronic spinal cord injury.
Gu B; Olejar KJ; Reiter JP; Thor KB; Dolber PC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1266-72. PubMed ID: 15152026
[TBL] [Abstract][Full Text] [Related]
20. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
Mandal AK; Kellar KJ; Gillis RA
J Pharmacol Exp Ther; 1991 May; 257(2):861-9. PubMed ID: 1674536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
